Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Ross

Showing results (851-860 of 927) with videos related to

Pageof 93
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal modelsJ P Steiner, G S Hamilton, D T Ross, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
BMC Cancer|March 24, 2010
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrenceDavid G Hicks, Bagi R Janarthanan, Ramya Vardarajan, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 12, 2020
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model SystemsTrenton T Ross, Collin Crowley, Kenneth L Kelly, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
In Pursuit of an Allosteric Human Tropomyosin Kinase A (<i>h</i>TrkA) Inhibitor for Chronic PainGovindan Subramanian, Brian Duclos, Paul D Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology studyJohn M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.
BMC Cancer|April 15, 2022
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancerHarsha Ranganath, Amit L Jain, Justin R Smith, et al.
Cell Stem Cell|April 10, 2008
N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cellsJeffrey S Haug, Xi C He, Justin C Grindley, et al.
Genomics|May 8, 1998
Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genesE van de Vosse, S M Walpole, A Nicolaou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
Pageof 93

Showing results (851-860 of 927) with videos related to

Sort By:
Pageof 93
Proceedings of the National Academy of Sciences of the United States of America|March 4, 1997
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal modelsJ P Steiner, G S Hamilton, D T Ross, et al.
Journal of Medicinal Chemistry|September 1, 1980
6-(Phenylthio)-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines, a novel class of dopamine receptor antagonists and neurolepticsC Kaiser, F E Ali, W E Bondinell, et al.
BMC Cancer|March 24, 2010
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrenceDavid G Hicks, Bagi R Janarthanan, Ramya Vardarajan, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 12, 2020
Acetyl-CoA Carboxylase Inhibition Improves Multiple Dimensions of NASH Pathogenesis in Model SystemsTrenton T Ross, Collin Crowley, Kenneth L Kelly, et al.
ACS Medicinal Chemistry Letters|November 19, 2021
In Pursuit of an Allosteric Human Tropomyosin Kinase A (<i>h</i>TrkA) Inhibitor for Chronic PainGovindan Subramanian, Brian Duclos, Paul D Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Mammostrat as an immunohistochemical multigene assay for prediction of early relapse risk in the tamoxifen versus exemestane adjuvant multicenter trial pathology studyJohn M S Bartlett, Kenneth J Bloom, Tammy Piper, et al.
BMC Cancer|April 15, 2022
Association of a novel 27-gene immuno-oncology assay with efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancerHarsha Ranganath, Amit L Jain, Justin R Smith, et al.
Cell Stem Cell|April 10, 2008
N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cellsJeffrey S Haug, Xi C He, Justin C Grindley, et al.
Genomics|May 8, 1998
Characterization of SCML1, a new gene in Xp22, with homology to developmental polycomb genesE van de Vosse, S M Walpole, A Nicolaou, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
Pageof 93